Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281258049> ?p ?o ?g. }
- W4281258049 endingPage "15" @default.
- W4281258049 startingPage "5" @default.
- W4281258049 abstract "Background: Corticosteroids and tocilizumab have been shown to improve survival in patients who require supplemental oxygen from coronavirus disease 2019 (COVID-19) pneumonia. The optimal dose of immunosuppression for the treatment of COVID-19 acute respiratory distress syndrome (ARDS) is still unknown. Objective: The objective of this study was to evaluate the effectiveness and safety of high- versus low-dose corticosteroids with or without tocilizumab for the treatment of COVID-19 ARDS. Methods: This was a retrospective study of patients admitted to the intensive care unit (ICU) requiring mechanical ventilation who received high- versus low-dose corticosteroids with or without tocilizumab. The primary outcome was survival to discharge. Safety outcomes included infections and incidence of hyperglycemia. Results: In this cohort, 110 (54%) and 95 (46%) patients received high-dose (≥10 mg dexamethasone equivalent) and low-dose (<10 mg dexamethasone equivalent) corticosteroids for more than 3 consecutive days, respectively. Thirty-five patients (32%) in the high-dose group and 33 patients (35%) in the low-dose group survived to hospital discharge ( P = 0.85). There was no difference in 28-day mortality in patients who received high-dose corticosteroids without tocilizumab compared with those who received low-dose corticosteroids with tocilizumab (n = 38/82, 46% vs n = 19/40, 48% P = 0.99); however, there was a higher mortality if patients received low-dose corticosteroids without tocilizumab (n = 39/55, 71%, P = 0.01). The highest rate of a bacterial pneumonia was in patients who received high-dose corticosteroids with tocilizumab. Conclusions: In critically ill patients with COVID-19 ARDS requiring mechanical ventilation, we found no difference in high- versus low-dose corticosteroids with regard to survival to hospital discharge. However, patients receiving only low-dose corticosteroids without tocilizumab did worse than the other groups. Larger prospective studies are needed to determine the optimal immunosuppression dosing strategy in this patient population." @default.
- W4281258049 created "2022-05-23" @default.
- W4281258049 creator A5006033224 @default.
- W4281258049 creator A5006204497 @default.
- W4281258049 creator A5006472394 @default.
- W4281258049 creator A5011703939 @default.
- W4281258049 creator A5016294361 @default.
- W4281258049 creator A5024399363 @default.
- W4281258049 creator A5025532006 @default.
- W4281258049 creator A5048070997 @default.
- W4281258049 creator A5051219993 @default.
- W4281258049 creator A5060013951 @default.
- W4281258049 creator A5084533616 @default.
- W4281258049 creator A5086591308 @default.
- W4281258049 date "2022-05-19" @default.
- W4281258049 modified "2023-09-25" @default.
- W4281258049 title "The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome" @default.
- W4281258049 cites W1968436319 @default.
- W4281258049 cites W1995121548 @default.
- W4281258049 cites W2144674187 @default.
- W4281258049 cites W2769689735 @default.
- W4281258049 cites W2902671349 @default.
- W4281258049 cites W3007104434 @default.
- W4281258049 cites W3015696390 @default.
- W4281258049 cites W3036853141 @default.
- W4281258049 cites W3037135479 @default.
- W4281258049 cites W3037673944 @default.
- W4281258049 cites W3081721922 @default.
- W4281258049 cites W3081877184 @default.
- W4281258049 cites W3082108964 @default.
- W4281258049 cites W3082355253 @default.
- W4281258049 cites W3082704225 @default.
- W4281258049 cites W3095368098 @default.
- W4281258049 cites W3110367200 @default.
- W4281258049 cites W3110844195 @default.
- W4281258049 cites W3129869280 @default.
- W4281258049 cites W3191782947 @default.
- W4281258049 cites W3206865065 @default.
- W4281258049 cites W4200141674 @default.
- W4281258049 cites W4206449744 @default.
- W4281258049 cites W4210642183 @default.
- W4281258049 doi "https://doi.org/10.1177/10600280221094571" @default.
- W4281258049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35590468" @default.
- W4281258049 hasPublicationYear "2022" @default.
- W4281258049 type Work @default.
- W4281258049 citedByCount "3" @default.
- W4281258049 countsByYear W42812580492023 @default.
- W4281258049 crossrefType "journal-article" @default.
- W4281258049 hasAuthorship W4281258049A5006033224 @default.
- W4281258049 hasAuthorship W4281258049A5006204497 @default.
- W4281258049 hasAuthorship W4281258049A5006472394 @default.
- W4281258049 hasAuthorship W4281258049A5011703939 @default.
- W4281258049 hasAuthorship W4281258049A5016294361 @default.
- W4281258049 hasAuthorship W4281258049A5024399363 @default.
- W4281258049 hasAuthorship W4281258049A5025532006 @default.
- W4281258049 hasAuthorship W4281258049A5048070997 @default.
- W4281258049 hasAuthorship W4281258049A5051219993 @default.
- W4281258049 hasAuthorship W4281258049A5060013951 @default.
- W4281258049 hasAuthorship W4281258049A5084533616 @default.
- W4281258049 hasAuthorship W4281258049A5086591308 @default.
- W4281258049 hasBestOaLocation W42812580491 @default.
- W4281258049 hasConcept C126322002 @default.
- W4281258049 hasConcept C141983124 @default.
- W4281258049 hasConcept C2776348555 @default.
- W4281258049 hasConcept C2776376669 @default.
- W4281258049 hasConcept C2776715498 @default.
- W4281258049 hasConcept C2777080012 @default.
- W4281258049 hasConcept C2777178219 @default.
- W4281258049 hasConcept C2777575956 @default.
- W4281258049 hasConcept C2777714996 @default.
- W4281258049 hasConcept C2777914695 @default.
- W4281258049 hasConcept C2780401358 @default.
- W4281258049 hasConcept C42219234 @default.
- W4281258049 hasConcept C71924100 @default.
- W4281258049 hasConceptScore W4281258049C126322002 @default.
- W4281258049 hasConceptScore W4281258049C141983124 @default.
- W4281258049 hasConceptScore W4281258049C2776348555 @default.
- W4281258049 hasConceptScore W4281258049C2776376669 @default.
- W4281258049 hasConceptScore W4281258049C2776715498 @default.
- W4281258049 hasConceptScore W4281258049C2777080012 @default.
- W4281258049 hasConceptScore W4281258049C2777178219 @default.
- W4281258049 hasConceptScore W4281258049C2777575956 @default.
- W4281258049 hasConceptScore W4281258049C2777714996 @default.
- W4281258049 hasConceptScore W4281258049C2777914695 @default.
- W4281258049 hasConceptScore W4281258049C2780401358 @default.
- W4281258049 hasConceptScore W4281258049C42219234 @default.
- W4281258049 hasConceptScore W4281258049C71924100 @default.
- W4281258049 hasIssue "1" @default.
- W4281258049 hasLocation W42812580491 @default.
- W4281258049 hasLocation W42812580492 @default.
- W4281258049 hasLocation W42812580493 @default.
- W4281258049 hasOpenAccess W4281258049 @default.
- W4281258049 hasPrimaryLocation W42812580491 @default.
- W4281258049 hasRelatedWork W2114198201 @default.
- W4281258049 hasRelatedWork W2147208203 @default.
- W4281258049 hasRelatedWork W2359845927 @default.
- W4281258049 hasRelatedWork W2407102458 @default.
- W4281258049 hasRelatedWork W2411294595 @default.